Quick Answer
MAIA Biotechnology, Inc. reported Total Assets of $9.70 million for fiscal year 2025.
MAIA Biotechnology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $9.70M | -4.4% |
| 2024 | $10.16M | +34.2% |
| 2023 | $7.57M | -37.1% |
| 2022 | $12.02M | +6.1% |
| 2021 | $11.33M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.78M | +27.5% | +6.7% |
| June 30, 2025 | $11.05M | -8.1% | -6.9% |
| March 31, 2025 | $11.86M | +36.1% | +16.8% |
| December 31, 2024 | $10.16M | +34.2% | +9.9% |
| September 30, 2024 | $9.24M | +32.0% | -23.1% |
| June 30, 2024 | $12.02M | +17.1% | +37.9% |
| March 31, 2024 | $8.72M | -3.9% | +15.2% |
| December 31, 2023 | $7.57M | -37.1% | +8.1% |
- MAIA Biotechnology, Inc. showed a decrease of -4.4% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, MAIA Biotechnology, Inc.’s total assets has declined by 14.3% (from $11.33 million to $9.70 million).
- The most recent figure is from MAIA Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: